Spyre Therapeutics
SYRE
#2075
Rank
C$12.72 B
Marketcap
C$134.03
Share price
-4.26%
Change (1 day)
291.79%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2026 (TTM): C-$3.93

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is C-$4.02. In 2025 the company made an earnings per share (EPS) of C-$2.95 an increase over its 2024 EPS that were of C-$5.34.

EPS history for Spyre Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$3.9333.37%
2025C-$2.95-44.82%
2024C-$5.34